ARKG vs MSFT: Which Stock is Better?
Side-by-side comparison of Ark Genomic Revolution Etf and Microsoft Corp in 2026
ARKG
Ark Genomic Revolution Etf
$27.93
MSFT
Microsoft Corp
$404.14
Key Metrics Comparison
| Metric | ARKG | MSFT | Winner |
|---|---|---|---|
| Market Cap | N/A | N/A | Tie |
| P/E Ratio | N/A | 25.38 | MSFT |
| EPS (TTM) | $N/A | $15.99 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze ARKG
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARKG or MSFT a better investment?
Comparing ARKG and MSFT: Ark Genomic Revolution Etf has a market cap of N/A while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARKG and MSFT?
ARKG (Ark Genomic Revolution Etf) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARKG or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARKG or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for ARKG.
Which company is more profitable: ARKG or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for ARKG.
Which is the larger company: ARKG or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of N/A compared to N/A for ARKG.
Should I buy ARKG or MSFT in 2026?
Both ARKG and MSFT have investment merit. ARKG trades at $27.93 while MSFT trades at $404.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARKG and MSFT stock?
Key differences: Market Cap (N/A vs N/A), P/E Ratio (N/A vs 25.4x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).